Cargando…
Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
During the past decade, there has been a revolution in cancer therapeutics by the emergence of antibody-based immunotherapies that modulate immune responses against tumors. These therapies have offered treatment options to patients who are no longer responding to classic anti-cancer therapies. By bl...
Autores principales: | Ibis, Betul, Aliazis, Konstantinos, Cao, Carol, Yenyuwadee, Sasitorn, Boussiotis, Vassiliki A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277501/ https://www.ncbi.nlm.nih.gov/pubmed/37342323 http://dx.doi.org/10.3389/fimmu.2023.1197364 |
Ejemplares similares
-
The evolving role of tissue-resident memory T cells in infections and cancer
por: Yenyuwadee, Sasitorn, et al.
Publicado: (2022) -
SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022) -
Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma
por: Yeo, Alan T., et al.
Publicado: (2023) -
Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
por: Gan, Linyang, et al.
Publicado: (2023) -
Immune-related adverse events of immune checkpoint inhibitors: a review
por: Yin, Qinan, et al.
Publicado: (2023)